Федеральное государственное бюджетное образовательное учреждение высшего образования "Дагестанский государственный медицинский университет" Министерства здравоохранения Российской Федерации (RU)
FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to gynaecology, and can be used for treating osteopenic syndrome in postmenopausal obesity women. That is ensured by prescribing Estrogel - 17-β oestradiol gel 0.5 dose (1.25 g of gel) once a day in a continuous mode, Morozestan in dose of 100 mg intravaginally in a continuous mode combined with preparation Aquadetrim 2 drops day (1000 ME) for one year with subsequent control of bone metabolism and bone mineral density.EFFECT: method enables reducing the frequency of osteopenia and stenoporosis, replenishing vitamin D deficiency with expressed protective effect on the entire skeleton.1 cl, 5 tbl, 2 ex, 2 dwg
